Plan debates usually return to scheduling and bans. India and the United States equally confront variations of the identical question: whether to impose broader, class-broad controls around fentanyl analogs and their precursors, or to help keep material-by-compound scheduling that will lag at the rear of traffickers’ innovation.A Daring and unapo